EIT Health Innovation Validation Call 2027

EIT Health (European Institute of Innovation and Technology) has launched its Innovation Validation Call for 2027. It offers fundingfor projects focusing on digital and AI-enabled medical technologies approaching market launch. Funding covers clinical studies and evidence collection to assess safety and efficacy, support regulatory approval and prepare for commercialisation. 

Who can apply? What is expected?

Applications must come from consortia of at least two organisations from different countries, representing at least two sides of the Knowledge Triangle: industry, research and education. A company responsible for commercialising the solution must lead the project. Eligible solutions are digital or AI-enabled medical devices covered by the Medical Devices Regulation (MDR) or In Vitro Diagnostic Medical Devices Regulation (IVDR). They must be at Innovation Maturity Level (IML) 6 and aim to reach IML 7 by the end of the project. Further details on these levels are available in EIT Health’s Healthcare Innovation Cycle Framework. Solutions must have the potential to benefit 150,000 patients or citizens in the EU. 

Funding and financial conditions

EIT Health will cover up to 50% of the total project budget, with a maximum grant of €850,000 per project.

The commercialising company must sign a Financial Sustainability Contribution Agreement. If this company is a micro or small enterprise, it must receive between €400,000 and €500,000 of the grant.

Key dates and more information 

• Call opening: 14 October 2026
• Application deadline: 13 January 2027
• Open Q&A session: 1 December 2026 at 15:00 CET – Q&A session registration

The official call document and supporting documents set out the full requirements and conditions. More information is also available on the call's website.